Penn Study Finds Taking Semaglutide for Weight Management Does Not Increase Risk of Depression or Suicidal Behavior in People Without Known Major Psychopathology
September 04, 2024
September 04, 2024
UNIVERSITY CITY, Pennsylvania, Sept. 4 (TNSres) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
Analysis of over 3,500 participants in clinical trials finds no increased risk of mental health issues among those using the weight loss medication
* * *
PHILADELPHIA-- Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal . . .
* * *
Analysis of over 3,500 participants in clinical trials finds no increased risk of mental health issues among those using the weight loss medication
* * *
PHILADELPHIA-- Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal . . .